Stabilized formulations of CNS compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10149853
APP PUB NO 20150086629A1
SERIAL NO

14261709

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • SUPERNUS PHARMACEUTICALS INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bhatt, Padmanabh P Rockville, US 66 579
Chang, Rong-Kun Rockville, US 38 1311
Huang, Austin B N. Potomac, US 11 13
Liang, Likan Boyds, US 40 487
Patel, Sachin V Derwood, US 31 350
Vieira, Michael L Gaithersburg, US 23 76

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 11, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 11, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00